Characterization of tumor-associated microbiome in multifocal small intestinal neuroendocrine tumors (SI-NETs)

I T Lee1,2, A Dohlman1,2, T Gao1

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, USA.

PubMed
Abstract

Insights

The gut microbiome in small intestinal neuroendocrine tumors (SI-NETs) is unique to each patient. Current research indicates that specific microorganisms within the tumors are unlikely to drive SI-NET development.

Area of Science:

  • Gastroenterology
  • Oncology
  • Microbiology

Background:

  • Small intestinal neuroendocrine tumors (SI-NETs) are common but their molecular pathogenesis remains unclear.
  • The multifocal nature and distal ileum enrichment of SI-NETs suggest potential environmental influences, possibly pathogenic organisms.
  • This study investigates the role of the tumor-associated microbiome in SI-NET development.

Purpose of the Study:

  • To characterize the tissue-resident ileal microbiome in multifocal SI-NET patients.
  • To explore the potential role of the microbiome in SI-NET pathogenesis.
  • To identify specific microbial signatures associated with SI-NETs.

Main Methods:

  • Whole genome and transcriptome sequencing of 70 primary ileal NETs from 10 patients.
  • Matched normal ileal mucosa and/or whole blood specimens were analyzed.
  • Microbiome composition analysis of ileal tissue samples.

Main Results:

  • Ileal tissue harbored distinct, patient-specific bacterial communities.
  • Abundant genera included common gastrointestinal, oral, and mucosal bacteria.
  • No significant differences in microbiota composition were observed between NET and normal tissues, though *Propionibacterium* was enriched in normal tissue.

Conclusions:

  • The ileal microbiome in multifocal SI-NET patients is largely patient-specific.
  • Genus-level analysis suggests individual microorganisms within tumors are unlikely drivers of SI-NET pathogenesis.
  • Further research is needed to fully elucidate the complex interplay between the microbiome and SI-NET development.

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.4K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.8K
Anatomy of the Intestines01:23

Anatomy of the Intestines

Although digestion of proteins, carbohydrates, and lipids may begin in the stomach, it is completed in the intestine. The absorption of nutrients, water, and electrolytes from food and drink also occurs in the intestine. The intestines can be divided into two structurally distinct organs—the small and large intestines.
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
87.5K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
6.1K